MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth

Author： Millot G.A.   Feger F.   Garcon L.   Vainchenker W.   Dumenil D.   Svinarchuk F.  

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.30, Iss.2, 2002-02, pp. : 166-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombopoietin

By Bolam S.  

Transfusion Science, Vol. 18, Iss. 1, 1997-03 ,pp. : 129-137

Elsevier

Access to resources Recommend Favorite

Thrombopoietin

By Bolam S.  

Transfusion and Apheresis Science, Vol. 18, Iss. 1, 1997-03 ,pp. : 129-137

Elsevier

Access to resources Recommend Favorite

The biology of thrombopoietin and thrombopoietin receptor agonists

By Kuter David  

International Journal of Hematology, Vol. 98, Iss. 1, 2013-07 ,pp. : 10-23

Springer Publishing Company

Access to resources Recommend Favorite

Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl - elements that control interactions of cytoplasmic signaling proteins

By Okabe S.   Tauchi T.   Morita H.   Ohashi H.   Yoshimura A.   Ohyashiki K.  

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1542-1547

Elsevier

Access to resources Recommend Favorite

Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function

By Kojima H.   Shinagawa A.   Shimizu S.   Kanada H.   Hibi M.   Hirano T.   Nagasawa T.  

Experimental Hematology, Vol. 29, Iss. 5, 2001-05 ,pp. : 616-622

Elsevier

Access to resources Recommend Favorite